Literature DB >> 9112967

A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy.

P Steinbok1, A M Reiner, R Beauchamp, R W Armstrong, D D Cochrane, J Kestle.   

Abstract

A randomized controlled single-blind trial was performed to compare lumbo-sacral selective posterior rhizotomy (SPR) followed by intensive physiotherapy, with intensive physiotherapy alone in improving motor function in children with spastic diplegic cerebral palsy. Fifteen patients were randomly assigned to each treatment modality. Patients in the SPR group had rhizotomy within 1 month, followed by intensive outpatient physiotherapy for 9 months. Patients assigned to physiotherapy alone had identical intensive physiotherapy. There was a statistically significant and clinically important difference in improvement in motor function in favor of the SPR group, with a mean increase in total Gross Motor Function Measure (GMFM) score of 11.3% at 9 months for the SPR group compared with 5.2% for the physiotherapy-only group (P = 0.007). Significant improvements in spasticity (P < 0.001) and range of movement (P < 0.001) were noted in the SPR group compared to the physiotherapy-only group. The results indicate that the improvement in motor function after SPR is more than can be explained by the associated intensive physiotherapy.

Entities:  

Mesh:

Year:  1997        PMID: 9112967     DOI: 10.1111/j.1469-8749.1997.tb07407.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  23 in total

Review 1.  Therapeutic choices in the locomotor management of the child with cerebral palsy--more luck than judgement?

Authors:  J H Patrick; A P Roberts; G F Cole
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

Review 2.  Intrathecal baclofen, selective dorsal rhizotomy, and extracorporeal shockwave therapy for the treatment of spasticity in cerebral palsy: a systematic review.

Authors:  Amogh Kudva; Mickey E Abraham; Justin Gold; Neal A Patel; Julian L Gendreau; Yehuda Herschman; Antonios Mammis
Journal:  Neurosurg Rev       Date:  2021-04-19       Impact factor: 3.042

3.  Effect of selective dorsal rhizotomy in the treatment of children with cerebral palsy.

Authors:  Jack R Engsberg; Sandy A Ross; David R Collins; Tae Sung Park
Journal:  J Neurosurg       Date:  2006-07       Impact factor: 5.115

Review 4.  Lumbosacral Dorsal Rhizotomy for Spastic Cerebral Palsy: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-06

5.  Improving access to selective dorsal rhizotomy for children with cerebral palsy.

Authors:  Benjamin Davidson; Darcy Fehlings; Golda Milo-Manson; George M Ibrahim
Journal:  CMAJ       Date:  2019-11-04       Impact factor: 8.262

6.  Predictors of poor outcome after selective dorsal rhizotomy in treatment of spastic cerebral palsy.

Authors:  Hyeon Sook Kim; Paul Steinbok; Diane Wickenheiser
Journal:  Childs Nerv Syst       Date:  2005-05-19       Impact factor: 1.475

Review 7.  Selective dorsal rhizotomy: current state of practice and the role of imaging.

Authors:  David Graham; Kristian Aquilina; Kshitij Mankad; Neil Wimalasundera
Journal:  Quant Imaging Med Surg       Date:  2018-03

8.  Selective dorsal rhizotomy for children with cerebral palsy: the Oswestry experience.

Authors:  G F Cole; S E Farmer; A Roberts; C Stewart; J H Patrick
Journal:  Arch Dis Child       Date:  2007-05-02       Impact factor: 3.791

9.  Predicting functional change from preintervention measures in selective dorsal rhizotomy.

Authors:  Jack R Engsberg; Sandy A Ross; David R Collins; Tae Sung Park
Journal:  J Neurosurg       Date:  2007-04       Impact factor: 5.115

10.  Preoperative MRI findings and functional outcome after selective dorsal rhizotomy in children with bilateral spasticity.

Authors:  Sebastian Grunt; Jules G Becher; Petra van Schie; Willem J R van Ouwerkerk; Mazarin Ahmadi; R Jeroen Vermeulen
Journal:  Childs Nerv Syst       Date:  2009-10-13       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.